Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Ucb Biopharma Sprl
Ucb Biopharma Sprl A Corporation
  

Ucb Biopharma Sprl patents

Recent patent applications related to Ucb Biopharma Sprl. Ucb Biopharma Sprl is listed as an Agent/Assignee. Note: Ucb Biopharma Sprl may have other listings under different names/spellings. We're not affiliated with Ucb Biopharma Sprl, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Ucb Biopharma Sprl-related inventors




Date Ucb Biopharma Sprl patents (updated weekly) - BOOKMARK this page
07/20/17Molecules with specificity for cd79 and cd22
07/20/17Molecules with specificity for cd45 and cd79
07/20/17Multispecific antibody constructs
06/08/17Imidazopyridine derivatives as modulators of tnf activity
06/01/17Method for determining antibody specificity
05/25/17Biological products
05/18/17Method and system for generating and displaying structured topics of a healthcare treatment taxonomy in different formats
05/18/17Method and system for generating and displaying topics in raw uncategorized data and for categorizing such data
05/18/17Method and system for generating and visually displaying inter-relativity between topics of a healthcare treatment taxonomy
05/11/17Fused imidazole and pyrazole derivatives as modulators of tnf activity
05/11/17Tetrahydroimidazopyridine derivatives as modulators of tnf activity
05/11/17Triazolopyridazine derivatives as modulators of tnf activity
05/11/17Fused bicyclic heteroaromatic derivatives as kinase inhibitors
05/04/17Pyrazolo-pyridine derivatives as kinase inhibitors
05/04/17Fused bicyclic heteroaromatic derivatives as kinase inhibitors
04/20/17Pharmaceutical compositions comprising levocetirizine
03/30/17Multimeric fc proteins
03/23/17Pyrazolopyridine derivatives as modulators of tnf activity
03/23/17New bispecific format suitable for use in high-through-put screening
03/23/17Multimeric fc proteins
02/02/17Multimeric fc proteins
01/12/17Auto-injector
01/05/17Auto-injector
01/05/17Synthetic promoters
12/29/16Fused tricyclic imidazole derivatives as modulators of tnf activity
12/29/16Imidazopyridazine derivatives as modulators of tnf activity
12/29/16Imidazotriazine derivatives as modulators of tnf activity
12/29/16Imidazothiazole derivatives as modulators of tnf activity
12/22/16Methods for treating parkinson's disease
12/08/16Imidazopyridine derivatives as modulators of tnf activity
11/17/16Process for reconstitution of a solid form of a pharmaceutical composition
11/10/16Biological products
11/03/16Anti-ap2 antibodies and antigen binding agents to treat metabolic disorders
10/20/16Fused bicyclic heteroaromatic derivatives as modulators of tnf activity
10/20/16Imidazopyridine derivatives as modulators of tnf activity
10/20/16Triazolopyridine derivatives as modulators of tnf activity
10/20/16Imidazopyridine derivatives as modulators of tnf activity
10/20/16Tetrahydroimidazopyridine derivatives as modulators of tnf activity
10/20/16Fused tricyclic benzimidazoles derivatives as modulators of tnf activity
10/20/16Fused tricyclic imidazole derivatives as modulators of tnf activity
10/13/16Tetrahydrobenzimidazole derivatives as modulators of tnf activity
10/13/16Benzotriazole derivatives as modulators of tnf activity
10/13/16Purine derivatives as modulators of tnf activity
10/13/16Imidazopyrimidine derivatives as modulators of tnf activity
10/13/16Fused imidazole and pyrazole derivatives as modulators of tnf activity
10/06/16Tetrahydroimidazopyridine derivatives as modulators of tnf activity
10/06/16Antibody molecules having binding specificity for human il-13
09/15/16Antibodies specific to fcrn
08/04/16Methods of treating pain using function modifying nav1.7 antibodies
07/14/16Method for the treatment of fibrotic disease
07/14/16Antibodies
07/07/16Method to generate antibodies to ion channels
07/07/16Injector
06/23/16Assembly for an autoinjector device
05/19/16Block decoys
05/05/16Obtaining an improved therapeutic ligand
03/31/16Methods to produce particles comprising therapeutic proteins
03/10/16Pd-1 antibodies
02/11/16Antibody molecules having specificity for human il-6
02/04/16Antibody molecules having specificity for human 0x40
01/21/16Single linker fabfv antibodies and methods of producing same
10/01/15Therapeutically active oxazoline derivatives
09/17/15Auto-injector
09/10/15Methods for producing recombinant proteins
08/20/15Function modifying nav1.7 antibodies
Patent Packs
08/06/15Antibody molecules which bind il-17a and il-17f
07/23/15Auto-injector
07/23/15Imidazopyridine derivatives as modulators of tnf activity
07/23/15Antibodies to ion channels
07/09/15Imidazopyrazine derivatives as modulators of tnf activity
07/02/15Auto-injector
06/18/15Auto-injector
06/04/15Tnf -alpha modulating benzimidazoles
04/30/15Anti-fcrn antibodies
07/23/15Imidazopyridine derivatives as modulators of tnf activity







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ucb Biopharma Sprl in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ucb Biopharma Sprl with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';